The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

Xi'an Jiaotong University

Status: Not yet enrolling

Conditions: HCV Infection; HCV Elimination

Treatments: Procedure: Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C

Study type: Observational

Funder types: Other

Identifiers

NCT06952036

XJTU1AF2024LSYY-413

Details and patient eligibility

About

The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women.

To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.

Enrollment: 200,000 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Pregnant women or parturient women confirmed by blood HCG test.
2. Patients aged 18 years old and above.
3. Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.

Exclusion criteria

1. Patients without valid telephone numbers.
2. Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.

Trial design

200,000 participants in 1 patient group

Pregnant women who had an antenatal visit or gave birth between 2014 and 2023.

Treatment:

Procedure: Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C